Ujhelyi E, Illei G, Böhm U, Füst G, Dierich M M, Szelényi J, Merétey K, Hofbauer J, Hollán S R
National Institute of Haematology and Blood Transfusion, Budapest, Hungary.
Haematologia (Budap). 1990;23(1):3-7.
129 sera with known antibody titres against E. coli 026 and E. coli 055 strains were tested with the Abbot second generation anti-HTLV III recombinant screening assay. No difference in the O.D. values was found between sera with high, normal and low anti-E. coli titres. In addition, no false-positive reactions were observed with the anti-HIV negative sera containing E. coli antibodies in high titres in a Western blot assay in which recombinant env antigen was applied. These results suggest that E. coli assays in which E. coli-produced recombinant antigens are used.
用雅培第二代抗人嗜T淋巴细胞病毒III型重组筛选试验检测了129份已知抗大肠杆菌O26和O55菌株抗体滴度的血清。抗大肠杆菌滴度高、正常和低的血清之间在光密度值上未发现差异。此外,在应用重组env抗原的蛋白质印迹试验中,对于高滴度含大肠杆菌抗体的抗HIV阴性血清,未观察到假阳性反应。这些结果表明使用了大肠杆菌产生的重组抗原的大肠杆菌检测方法。